The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9120812, 254 ID: ALA3940347
Chembl Id: CHEMBL3940347
PubChem CID: 71667456
Max Phase: Preclinical
Molecular Formula: C27H33FN6O4
Molecular Weight: 524.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCN1CC(C)(C)Oc2nc(N3C4CCC3COC4)nc(-c3ccc(NC(=O)NC4CC4)c(F)c3)c2C1=O
Standard InChI: InChI=1S/C27H33FN6O4/c1-4-33-14-27(2,3)38-23-21(24(33)35)22(31-25(32-23)34-17-8-9-18(34)13-37-12-17)15-5-10-20(19(28)11-15)30-26(36)29-16-6-7-16/h5,10-11,16-18H,4,6-9,12-14H2,1-3H3,(H2,29,30,36)
Standard InChI Key: JUZWAYFMLNXZNF-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 524.60Molecular Weight (Monoisotopic): 524.2547AlogP: 3.57#Rotatable Bonds: 5Polar Surface Area: 108.92Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.37CX Basic pKa: 3.96CX LogP: 3.53CX LogD: 3.53Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.62Np Likeness Score: -1.00
References 1. (2015) Pyrimidooxazocine derivatives as mTOR-inhibitors,